0.01CNY
102.52 MCNY
5.15 BCNY
9.11 B
About KANGMEI PHARMACEUTICAL CO., LTD
Sector
CEO
Guo Wei Liu
Headquarters
Shenzhen
Website
Employees (FY)
4.41 K
Founded
1997
ISIN
CNE0000017M1
FIGI
BBG000GW32N8
Kangmei Pharmaceutical Co., Ltd. engages in the trade, production, and sales of Chinese herbal medicine pieces, patent medicine preparations, health foods, chemicals and medical devices, modern pharmaceutical logistics system. It offers Chinese medicines, including American ginseng, notoginseng powder, salvia powder, radix codonopsis pilosulae, maltiflower knotweed, angelica and lonicera flower, among others, as well as chemical drugs, including Clarithromycin Dispersible Tablets, Doxazosin Mesylate Tablets, Propiverine Hydrochloride Tablets and paracetamol and pseudoephedrine hydrochloride tablets, among others. The company also provides property management services. Kangmei Pharmaceutical was founded on June 9, 1997 and is headquartered in Shenzhen, China.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 600518 is 1.92 CNY — it hasn't changed in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on SSE exchange KANGMEI PHARMACEUTICAL CO., LTD stocks are traded under the ticker 600518.
KANGMEI PHARMACEUTICAL CO., LTD is going to release the next earnings report on Apr 30, 2024. Keep track of upcoming events with our Earnings Calendar.
600518 stock is 2.63% volatile and has beta coefficient of 0.52. Check out the list of the most volatile stocks — is KANGMEI PHARMACEUTICAL CO., LTD there?
Yes, you can track KANGMEI PHARMACEUTICAL CO., LTD financials in yearly and quarterly reports right on TradingView.
600518 stock has fallen by 4.48% compared to the previous week, the month change is a 3.03% fall, over the last year KANGMEI PHARMACEUTICAL CO., LTD has showed a 7.69% decrease.
600518 net income for the last quarter is 250.53 M CNY, while the quarter before that showed −22.15 M CNY of net income which accounts for 1.23 K% change. Track more KANGMEI PHARMACEUTICAL CO., LTD financial stats to get the full picture.
Today KANGMEI PHARMACEUTICAL CO., LTD has the market capitalization of 26.55 B, it has decreased by 0.93% over the last week.
Like other stocks, 600518 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade KANGMEI PHARMACEUTICAL CO., LTD stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 18, 2024, the company has 4.41 K employees. See our rating of the largest employees — is KANGMEI PHARMACEUTICAL CO., LTD on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So KANGMEI PHARMACEUTICAL CO., LTD technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating KANGMEI PHARMACEUTICAL CO., LTD stock shows the sell signal. See more of KANGMEI PHARMACEUTICAL CO., LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. KANGMEI PHARMACEUTICAL CO., LTD EBITDA is 379.62 M CNY, and current EBITDA margin is 9.71%. See more stats in KANGMEI PHARMACEUTICAL CO., LTD financial statements.